![]() |
|
|
Manuscript received 9 September 1996. Initial reviews completed 4 October 1996. Revision accepted 30 January 1997.
Department of Pharmacology and Therapeutics, Louisiana State University Medical Center, Shreveport, Louisiana 71130
Although reabsorption across the apical (AP) membrane of the renal proximal tubule cell plays a vital role in the conservation of plasma 5-methyltetrahydrofolate, basolateral (BL) membrane-directed secretory pathways may also be important in regulating the urinary excretion of folate. Folate transport proteins, folate receptor and the reduced folate carrier have been implicated in the renal conservation of folate across the AP membrane, but their role in BL membrane-directed folate transport has not been studied. 5-Methyltetrahydrofolate transport across the AP and BL membranes of human proximal tubule cells was studied in cells grown on membrane inserts to allow optimum differentiation of AP and BL domains. Colchicine, an inhibitor of vesicular-mediated endocytosis, inhibited AP binding and AP-directed transport without affecting BL transport. Probenecid, an inhibitor of anion exchange, did not affect binding, but inhibited both AP and BL-directed transport with a greater effect on BL transport. Folic acid abolished AP binding of 5-methyltetrahydrofolate, but diminished AP-mediated transport by only 50%. These data suggest that both the folate receptor and the reduced folate carrier participate in AP uptake of folates by human kidney cells, but that BL-mediated uptake occurs primarily by the reduced folate carrier. Folate transport from the secretory direction occurred as readily as that from the reabsorptive direction, indicating that altered secretion could mediate excess urinary folate excretion.
Key words: humans, folate receptor, reduced folate carrier, urinary folate excretion, endocytosis.
This article has been cited by other articles:
![]() |
A. N. Elwi, V. L. Damaraju, M. L. Kuzma, D. A. Mowles, S. A. Baldwin, J. D. Young, M. B. Sawyer, and C. E. Cass Transepithelial fluxes of adenosine and 2'-deoxyadenosine across human renal proximal tubule cells: roles of nucleoside transporters hENT1, hENT2, and hCNT3 Am J Physiol Renal Physiol, June 1, 2009; 296(6): F1439 - F1451. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ashokkumar, Z. M Mohammed, N. D Vaziri, and H. M Said Effect of folate oversupplementation on folate uptake by human intestinal and renal epithelial cells Am. J. Clinical Nutrition, July 1, 2007; 86(1): 159 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Reddy, E. Westrick, H. K.R. Santhapuram, S. J. Howard, M. L. Miller, M. Vetzel, I. Vlahov, R. V.J. Chari, V. S. Goldmacher, and C. P. Leamon Folate Receptor-Specific Antitumor Activity of EC131, a Folate-Maytansinoid Conjugate Cancer Res., July 1, 2007; 67(13): 6376 - 6382. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Romanoff, D. M. Ross, and K. E. McMartin Acute Ethanol Exposure Inhibits Renal Folate Transport, but Repeated Exposure Upregulates Folate Transport Proteins in Rats and Human Cells J. Nutr., May 1, 2007; 137(5): 1260 - 1265. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Birn, O. Spiegelstein, E. I. Christensen, and R. H. Finnell Renal Tubular Reabsorption of Folate Mediated by Folate Binding Protein 1 J. Am. Soc. Nephrol., March 1, 2005; 16(3): 608 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Damaraju, K. F. Hamilton, M. L. Seth-Smith, C. E. Cass, and M. B. Sawyer Characterization of Binding of Folates and Antifolates to Brush-Border Membrane Vesicles Isolated from Human Kidney Mol. Pharmacol., February 1, 2005; 67(2): 453 - 459. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Theti and A. L. Jackman The Role of {alpha}-Folate Receptor-Mediated Transport in the Antitumor Activity of Antifolate Drugs Clin. Cancer Res., February 1, 2004; 10(3): 1080 - 1089. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Theti, V. Bavetsias, L. A. Skelton, J. Titley, D. Gibbs, G. Jansen, and A. L. Jackman Selective Delivery of CB300638, a Cyclopenta[g]quinazoline-based Thymidylate Synthase Inhibitor into Human Tumor Cell Lines Overexpressing the {alpha}-Isoform of the Folate Receptor Cancer Res., July 1, 2003; 63(13): 3612 - 3618. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Han, Y. Kato, H. Kusuhara, H. Suzuki, M. Shimoda, E. Kokue, and Y. Sugiyama Kinetic profile of overall elimination of 5-methyltetrahydropteroylglutamate in rats Am J Physiol Endocrinol Metab, March 1, 1999; 276(3): E580 - E587. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Gregory III, J. Williamson, J.-F. Liao, L. B. Bailey, and J. P. Toth Kinetic Model of Folate Metabolism in Nonpregnant Women Consuming [2H2]Folic Acid: Isotopic Labeling of Urinary Folate and the Catabolite para-Acetamidobenzoylglutamate Indicates Slow, Intake-Dependent, Turnover of Folate Pools J. Nutr., November 1, 1998; 128(11): 1896 - 1906. [Abstract] [Full Text] |
||||